Authors:
SCHRODER W
VERING A
STEGMULLER M
STROHMEIER R
Citation: W. Schroder et al., LYMPHOCYTE SUBSETS IN PATIENTS WITH OVARIAN AND BREAST-CANCER, European journal of gynaecological oncology, 18(6), 1997, pp. 474-477
Authors:
OREMEK GM
VERING A
STEGMULLER M
SEIFFERT UB
Citation: Gm. Oremek et al., DIAGNOSTIC-VALUE OF MAMMARY SERUM ANTIGEN -MSA AS TUMOR-MARKER FOR BREAST-CANCER, Die medizinische Welt, 47(11), 1996, pp. 463-466
Authors:
RAUSCHECKER HF
SAUER R
SCHAUER A
SCHUMACHER M
HAASE W
BECHT I
DORNOFF W
BRAUN M
FINKENWERDER H
SCHULTEOVERBERG G
NEUMANN R
VERING A
GEIER G
UNBEHAUN V
STAHLKUSCHEL S
SAUER U
MOORTHI K
GATZEMEIER W
BOHM C
EKUE S
STOSIEK U
STAIGER HF
SELCH A
KIEHN J
FRICKE B
SCHARSICH M
GOBEL R
OTT G
KIENLE B
KIFFNER E
OVERMANN E
LENTZEN M
SIEKMANN U
MEUSEL P
FISCHER M
GRILLO M
HEIDEGGER H
SALZ HP
BOOTHMAN G
BREITBACH GP
MINK D
BERGAUER O
KURZ E
BEYERLE C
ZIEGER W
EBERL M
BRUNNERT K
OLSCHEWSKI M
SAUERBRIE W
SEEGENSCHMIEDT MH
SCHMOOR C
Citation: Hf. Rauschecker et al., THERAPY OF SMALL BREAST-CANCER - 4-YEAR RESULTS OF A PROSPECTIVE NONRANDOMIZED STUDY, Breast cancer research and treatment, 34(1), 1995, pp. 1-13
Authors:
SCHNURCH HG
STEGMULLER M
VERING A
BECKMANN MW
BENDER HG
Citation: Hg. Schnurch et al., GROWTH-INHIBITION OF XENOTRANSPLANTED HUMAN CARCINOMAS BY A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE EPIDERMAL GROWTH-FACTOR RECEPTOR, European journal of cancer, 30A(4), 1994, pp. 491-496
Authors:
RUDEREANU D
VERING A
STEGMULLER M
BENDER HG
Citation: D. Rudereanu et al., ACTION OF THE PROGESTERONE ANTAGONIST ONA PRISTONE IN AN ENDOMETRIAL CARCINOMA ALLOGRAFT, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1065-1067
Citation: A. Vering et al., IMMUNOBIOCHEMICAL ASSAY FOR DETERMINATION OF NUCLEAR STEROID-RECEPTORS DURING TAMOXIFEN THERAPY, Journal of cancer research and clinical oncology, 119(7), 1993, pp. 415-420